Elevidys

Sarepta Sarepta Therapeutics

Sanofi sues Sarepta over 2 gene therapy manufacturing patents

Sanofi has filed a complaint claiming that in producing Duchenne muscular dystrophy treatment Elevidys, Sarepta encroaches on two of its patents.

Kevin Dunleavy Jul 30, 2024 5:21pm

Duchenne muscular dystrophy DMD

FDA broadens label for Sarepta's Duchenne gene therapy Elevidys

Jun 21, 2024 7:51am

setback chess beat defeat rook break

Pfizer's DMD loss is Sarepta's gain: analysts

Jun 13, 2024 10:58am

stop light green

Italfarmaco wins FDA's blessing for nonsteroidal DMD therapy

Mar 22, 2024 11:05am

Elevidys gains steam amid Sarepta's efforts to widen FDA label

Feb 29, 2024 4:11pm

Sarepta's Elevidys expansion bid gets fast review without adcomm

Feb 16, 2024 11:05am